EKF Diagnostics, the global in-vitro diagnostics company, announces that its Quo-Test ® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening ...

GROVE CITY, Ohio, Oct. 6, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation ...

Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...

Editor’s Note: This article originally appeared on Abbott’s website. ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the launch of its Afinion™ 2 analyzer in the U.S.

Please provide your email address to receive an email when new articles are posted on . Roche’s cobas c 513 analyzer and HbA1c Gen. 3 assay has received clearance from the FDA, according to a company ...

Trinity Biotech ( ($TRIB) ) just unveiled an update. On December 15, 2025, Trinity Biotech announced that it has secured regulatory clearances in ...